Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Stopped early · Phase 2 · Has a placebo group

Conditions studied: RSV Infection

In brief

The goal of this clinical study is to check if obeldesivir (ODV; GS-5245) is safe and well-tolerated by children with respiratory syncytial virus (RSV) infection. It will also look at how well ODV helps reduce the time it takes for children to feel better and for their RSV symptoms to improve. The primary objectives of this study are: a) to evaluate the safety and tolerability of ODV in pediatric participants with RSV infection; b) To evaluate the efficacy of ODV on time to alleviation of targeted RSV symptoms in pediatric participants with RSV infection.

Key facts

Study ID
NCT06784973
Run by
Gilead Sciences
People needed
4
Starts
2025-03-05
Expected to finish
2025-04-16
Last updated by the study team
2026-06-08

Who can join

Age: any, up to 5. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.